In tularemia, how do IgG and IgM serology results differ in indicating recent versus past infection?

Tularemia IgG versus IgM Positivity

IgM alone does NOT reliably indicate a recent tularemia infection; prioritize a ≥4-fold rise (seroconversion) on paired sera or concurrent PCR/culture, because both IgM and IgG can persist for months to years. 1, 2, 3, 4

• What IgM means

  • Often appears by 1–2 weeks after symptom onset; peaks around 1 month; can persist ≥4–12 months, and may cross-react (false positives) with Francisella philomiragia, Brucella, Proteus OX19, Yersinia pestis; thus, isolated IgM is not a secure marker of “recent” infection 2, 3.
  • Practical pitfall: a single positive IgM can reflect older infection or cross-reactivity; avoid over-calling acute disease on IgM alone 2.

• What IgG means

  • Rises a bit later (peaks ~2 months), persists for years; IgG positivity alone usually indicates past exposure, not necessarily active infection 3, 4.
  • Very long persistence: substantial proportions remain IgG-positive 8+ years post-infection; hence, single-sample IgG is poor for timing 4.

• Best way to determine “recent” versus “past”

  • Recent/ongoing infection: document a ≥4-fold rise or seroconversion between acute and convalescent sera collected 2–4 weeks apart; this is the guideline-preferred criterion and overcomes persistence issues of both IgM and IgG 2, 1.
  • Past infection: stable, single-sample IgG (with or without IgM) without a rising titer supports prior exposure; high titers alone are insufficient to time infection because antibodies can persist and wane slowly 2, 3, 4.

• Actionable algorithm to maximize patient outcomes (morbidity/mortality/QOL)

  • Suspect tularemia clinically: obtain acute serum now and order convalescent serum for 2–4 weeks later; alert lab for biosafety; add PCR/culture if feasible to expedite diagnosis and treatment decisions 1, 2.
  • Interpret results:
    • IgM+ and/or IgG+, single sample: do not time infection; treat based on clinical severity and epidemiology; repeat serology for rise/seroconversion 1, 2.
    • Rising (≥4-fold) IgG and/or IgM between paired sera or seroconversion: confirms recent infection—initiate/continue appropriate therapy promptly to prevent suppuration, pneumonia, and death 1.
    • Low-level persistent IgM or IgG without rise: likely past infection or cross-reactivity; reassess diagnosis and consider alternate etiologies 2, 3.
  • Caveats to avoid harm:
    • Do not rely on IgM to define “acute” due to persistence and cross-reactions; use paired titers 2, 3.
    • Elderly may mount lower titers; a lack of high titer does not exclude disease—clinical judgment plus paired testing is critical 3.
    • Vaccination/exposure can yield antibodies; serology cannot determine subspecies; use clinical-epidemiologic context 2.

• Evidence strength and recency

  • Guideline framing: serology preferred; paired sera 2–4 weeks apart recommended; single titers insufficient; cross-reactivity noted 1, 2.
  • Most recent high-quality study: ELISA-based kinetics show IgM peaks at 1 month, IgG at 2 months, with both persisting (IgM ≥4 months; IgG ≥12 months), underscoring why single IgM/IgG cannot time infection reliably 3.
  • Long-term persistence data: IgG frequently positive years later; some IgM detectable years after illness—supports caution with timing from single samples 4.